Melanotan II (MT2) 10mg

Dragon Pharma Melanotan II 10mg

Dragon Pharma Melanotan II 10mg is a pharmaceutical-grade MT2 peptide — a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) formulated at 10mg per vial as a sterile lyophilized powder. MT2 binds to melanocortin receptors throughout the body, triggering melanin production in skin cells for gradual, deep skin darkening without UV exposure, while also activating secondary receptor pathways linked to libido enhancement and appetite regulation.

As one of the most researched tanning peptides available for sale online, Dragon Pharma MT2 delivers verified concentration in a pharmaceutical-grade lyophilized format — offering researchers studying melanocortin receptor pathways, pigmentation biology, and related physiological effects a consistent, precisely dosed research compound.

What Is MT2 — How Dragon Pharma Melanotan II Works

Dragon Pharma Melanotan II 10mg operates through the melanocortin receptor system — binding to MC1R, MC3R, and MC4R receptors expressed across skin, brain, and peripheral tissues. Unlike natural tanning which requires UV radiation to activate melanocytes from the outside, MT2 peptide stimulates melanin production directly from within — triggering melanocytes in the basal layer of the epidermis to produce and release increased melanin without significant UV exposure.

• MC1R activation — primary receptor for melanin production; stimulates melanocytes to produce eumelanin (dark brown/black pigment) responsible for the deep, natural-looking tan MT2 is known for
• MC3R and MC4R activation — secondary receptors involved in appetite regulation, energy homeostasis, and sexual arousal pathways in the central nervous system; responsible for MT2's appetite suppression and libido enhancement effects
• Internal melanin stimulation — MT2 triggers melanin synthesis without requiring UV radiation as the initiating signal, allowing gradual skin darkening with significantly reduced photoaging and skin cancer risk compared to UV-dependent tanning

Dragon Pharma Melanotan II 10mg — Key Research Benefits

• Sunless tanning — MT2 peptide produces a gradual, deep skin darkening effect particularly valuable for fair-skinned research subjects where UV sensitivity makes conventional tanning high-risk; tanning effects typically visible within 7–14 days of consistent protocol administration
• Reduced UV exposure requirement — by stimulating melanin internally, Dragon Pharma Melanotan II 10mg significantly reduces the UV exposure needed to achieve and maintain a tan compared to natural tanning methods — lowering photoaging, sunburn, and UV-related skin damage risk
• Libido enhancement — MC4R activation in the central nervous system supports sexual arousal pathways; research subjects report increased libido and improved erectile function, making MT2 a studied compound in sexual function research
• Appetite suppression — MC3R and MC4R receptor activity influences appetite regulation and energy homeostasis; secondary appetite-reducing effects reported consistently across MT2 peptide research models
• Photoaging protection — melanin itself provides UV protection; elevated melanin levels from MT2 administration offer a layer of natural photoprotection reducing long-term UV-related skin aging markers

Dragon Pharma Melanotan II 10mg Dosage Guide

Dragon Pharma MT2 is supplied as a sterile lyophilized powder requiring reconstitution with bacteriostatic water before subcutaneous administration. The 10mg vial provides significantly more research material per vial than standard 5mg alternatives, supporting extended loading and maintenance phase protocols.

Administration notes:

• Administer via subcutaneous injection into abdominal or thigh tissue
• Evening administration recommended — nausea is the most common side effect and is better tolerated during sleep than during active daily hours
• A small amount of UV exposure (brief, controlled sun exposure) helps fully activate the melanin MT2 stimulates — though far less UV than required for natural tanning
• Store lyophilized powder in cool, dry, dark conditions before reconstitution; refrigerate after reconstitution and use within 30–60 days
• Always use sterile syringes and bacteriostatic water; clean injection site thoroughly before every administration

MT2 Peptide vs Natural Tanning

Research Stacking Protocols

Dragon Pharma Melanotan II 10mg is studied as a standalone tanning and libido research compound but can be incorporated into broader melanocortin pathway and skin health research stacks.

Skin Health and Anti-Inflammatory Stack:

• Dragon Pharma Melanotan II 10mg: 0.5mg daily — MC1R-driven melanin production and UV protection research
• KPV peptide: 200–500 mcg daily — NF-κB anti-inflammatory and skin barrier research; addresses inflammatory skin conditions (eczema, psoriasis, dermatitis) alongside MT2's pigmentation research

Skin Repair and Regeneration Stack:

• Dragon Pharma Melanotan II 10mg: 0.5mg daily — pigmentation and photoprotection research
• GHK-Cu peptide: standard research dose — collagen synthesis, elastin production, and skin tissue regeneration

Body Composition and Appetite Research Stack:

• Dragon Pharma Melanotan II 10mg: 0.5–1mg daily — MC3R/MC4R appetite suppression and energy homeostasis research
• AOD-9604 peptide: 300–500 mcg daily — targeted fat mobilization and lipolysis research

Side Effects of Dragon Pharma Melanotan II 10mg

Dragon Pharma Melanotan II 10mg carries a well-documented side effect profile consistent with its broad melanocortin receptor activity. Side effects are predominantly dose-dependent and most pronounced during the initial titration phase.

• Nausea and vomiting — most commonly reported effect, particularly during early dose escalation; managed by evening administration and conservative starting doses (0.25mg)
• Flushing and warmth — transient vasodilatory response post-injection; typically short-lived
• Hyperpigmentation — MT2 stimulates melanin production indiscriminately, darkening existing moles, freckles, and skin lesions; researchers should monitor skin changes throughout the protocol
• Elevated blood pressure and heart rate — cardiovascular monitoring recommended for research subjects with existing cardiovascular risk factors
• Spontaneous erections — MC4R activation may produce unsolicited erectile responses, particularly at higher doses; most pronounced during the loading phase
• Appetite suppression — can reduce caloric intake more than intended at higher doses; monitor nutritional intake throughout the research protocol
• Facial flushing — redness and warmth in facial tissue reported in a subset of research subjects

Important: due to MT2's effect on mole and freckle darkening, research subjects with a history of melanoma or high skin cancer risk require careful dermatological monitoring throughout any Melanotan II protocol.

Why Dragon Pharma Melanotan II 10mg?

Dragon Pharma's pharmaceutical-grade manufacturing ensures every vial of Melanotan II 10mg delivers verified MT2 peptide concentration — confirmed through independent third-party laboratory testing. Dragon Pharma Melanotan II 10mg provides:

• Confirmed 10mg MT2 peptide concentration per vial through independent third-party laboratory analysis — double the research material of standard 5mg vials for extended protocol coverage
• Pharmaceutical-grade lyophilized powder preserving full melanocortin receptor binding activity through reconstitution
• Trusted by researchers worldwide as the highest-concentration MT2 peptide option in the Dragon Pharma research peptide line